Comparing the current results to its competitors, Dr Reddy S Laboratories Limited reported Revenue decrease in the 4 quarter 2026 year on year by -6.06 %, despite the revenue increase by the most of its competitors of 6.19 %, recorded in the same quarter.
Publicly Traded Peers of Dr Reddy s Laboratories Limited
Abbvie Inc Share Performance
+14.56%
This Year
Abbvie Inc
Profile
AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry.
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
Perrigo Company Plc is a leading global healthcare supplier that focuses on providing affordable, high-quality over-the-counter (OTC) healthcare and wellness products. The company operates through its own worldwide distribution network, manufacturing a wide range of products and medications. By leveraging its extensive portfolio and efficient supply chain, Perrigo aims to enhance the well-being of consumers by making quality healthcare products more accessible.
Universe Pharmaceuticals Inc is a pharmaceutical company that follows a business model focused on research, development, and manufacturing of medications. They aim to identify and address unmet medical needs by developing innovative pharmaceutical products. Through strategic partnerships and collaborations, they strive to bring their products to market and provide effective healthcare solutions to patients worldwide.
Sources:
Dr Reddy s Laboratories Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Dr Reddy s Laboratories Limited versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
